Oncology Generics Medicines

The Common Services Agency (more commonly known as NHS National Services Scotland) ("the Authority")

This public procurement record has 2 releases in its history.

Award

24 Jan 2019 at 00:00

Tender

25 Sep 2018 at 01:00

Summary of the contracting process

The Common Services Agency, also known as NHS National Services Scotland, is conducting a procurement process for "Oncology Generics Medicines" aimed at supplying a range of Oncology Generic Medicines to Health Boards across NHS Scotland. This open tender, initiated on 25th September 2018, is currently at the active stage and includes 37 lots for various medicinal products, with the deadline for submissions set for 29th October 2018 at 12:00. The contract will be awarded based on quality and price, and suppliers are encouraged to bid for multiple lots.

Participating in this procurement process offers significant opportunities for pharmaceutical companies, particularly those specialising in oncology products. The framework agreement, which allows for a maximum of 24 months extension, will enable suppliers to establish or grow their business within Scotland's health sector. Businesses with existing UK Marketing Authorisations and certifications such as ISO 9001 will be well-positioned to compete effectively in this tender.

How relevant is this notice?

Notice Title

Oncology Generics Medicines

Notice Description

Supply of Oncology Generic Medicines to Health Boards across NHS Scotland

Lot Information

Lot 1 Bendamustine Powder For Solution For Infusion

Supply of Bendamustine Powder For Solution For Infusion to NHS Scotland. The Authority has awarded this Lot to a single supplier.

Renewal: The Authority is entitled at its sole discretion to extend the Framework Agreement for up to a maximum of twenty four (24) months by giving a minimum of three (3) months written notice of such extension(s).

Lot 2 Capecitabine Tablets

Supply of Capecitabine Tablets to NHS Scotland. The Authority has awarded this Lot to a single supplier.

Renewal: The Authority is entitled at its sole discretion to extend the Framework Agreement for up to a maximum of twenty four (24) months by giving a minimum of three (3) months written notice of such extension(s).

Lot 3 Carboplatin Injection

Supply of Carboplatin Injections to NHS Scotland. The Authority has awarded this Lot to a single supplier.

Renewal: The Authority is entitled at its sole discretion to extend the Framework Agreement for up to a maximum of twenty four (24) months by giving a minimum of three (3) months written notice of such extension(s).

Lot 4 Cisplatin Injection

Supply of Cisplatin Injections to NHS Scotland. The Authority has awarded this Lot to a single supplier.

Renewal: The Authority is entitled at its sole discretion to extend the Framework Agreement for up to a maximum of twenty four (24) months by giving a minimum of three (3) months written notice of such extension(s).

Lot 5 Cyclophosphamide Injection, Powder For Reconstitution

Supply of Cyclophosphamide Injection, Powder For Reconstitution to NHS Scotland. The Authority has awarded this Lot to a single supplier.

Renewal: The Authority is entitled at its sole discretion to extend the Framework Agreement for up to a maximum of twenty four (24) months by giving a minimum of three (3) months written notice of such extension(s).

Lot 6 Cytarabine Injections

Supply of Cytarabine Injections to NHS Scotland. The Authority has awarded this Lot to a single supplier.

Renewal: The Authority is entitled at its sole discretion to extend the Framework Agreement for up to a maximum of twenty four (24) months by giving a minimum of three (3) months written notice of such extension(s).

Lot 7 Dacarbazine Injections

Supply of Dacarbazine Injections to NHS Scotland. The Authority has awarded this Lot to a single supplier.

Renewal: The Authority is entitled at its sole discretion to extend the Framework Agreement for up to a maximum of twenty four (24) months by giving a minimum of three (3) months written notice of such extension(s).

Lot 8 Disodium Folinate Injection

Supply of Disodium Folinate Injections to NHS Scotland. The Authority has awarded this Lot to a single supplier.

Renewal: The Authority is entitled at its sole discretion to extend the Framework Agreement for up to a maximum of twenty four (24) months by giving a minimum of three (3) months written notice of such extension(s).

Lot 9 Docetaxel Concentrate For Solution For Infusion

Supply of Docetaxel Concentrate For Solution For Infusion to NHS Scotland. The Authority has awarded this Lot to a single supplier.

Renewal: The Authority is entitled at its sole discretion to extend the Framework Agreement for up to a maximum of twenty four (24) months by giving a minimum of three (3) months written notice of such extension(s).

Lot 10 Doxorubicin Hydrochloride Injections

Supply of Doxorubicin Hydrochloride Injections to NHS Scotland. The Authority has awarded this Lot to a single supplier.

Renewal: The Authority is entitled at its sole discretion to extend the Framework Agreement for up to a maximum of twenty four (24) months by giving a minimum of three (3) months written notice of such extension(s).

Lot 11 Imatinib

The supply of Imatinib to NHS Scotland. The Authority has awarded this Lot as a ranked multi-supplier award.

Renewal: The Authority is entitled at its sole discretion to extend the Framework Agreement for up to a maximum of twenty four (24) months by giving a minimum of three (3) months written notice of such extension(s).

Lot 12 Etoposide Injection

Supply of Etoposide Injection to NHS Scotland.The Authority has awarded this Lot to a single supplier.

Renewal: The Authority is entitled at its sole discretion to extend the Framework Agreement for up to a maximum of twenty four (24) months by giving a minimum of three (3) months written notice of such extension(s).

Lot 13 Fluorouracil 25MG/ML Injection

Supply of Fluorouracil 25MG/ML Injections to NHS Scotland. This Lot has not been awarded.

Renewal: The Authority is entitled at its sole discretion to extend the Framework Agreement for up to a maximum of twenty four (24) months by giving a minimum of three (3) months written notice of such extension(s).

Lot 14 Fluorouracil 50MG/ML Injection

Supply of Fluorouracil 50MG/ML Injections to NHS Scotland. The Authority has awarded this Lot to a single supplier.

Renewal: The Authority is entitled at its sole discretion to extend the Framework Agreement for up to a maximum of twenty four (24) months by giving a minimum of three (3) months written notice of such extension(s).

Lot 15 Gemcitabine 38MG/ML Concentrate For Solution For Infusion Vials

Supply of Gemcitabine 38MG/ML Concentrate For Solution For Infusion Vials to NHS Scotland. The Authority has awarded this Lot to a single supplier.

Renewal: The Authority is entitled at its sole discretion to extend the Framework Agreement for up to a maximum of twenty four (24) months by giving a minimum of three (3) months written notice of such extension(s).

Lot 16 Gemcitabine 100MG/ML Concentrate For Solution For Infusion Vials

Supply of Gemcitabine 100MG/ML Concentrate For Solution For Infusion Vials to NHS Scotland. The Authority has awarded this Lot to a single supplier.

Renewal: The Authority is entitled at its sole discretion to extend the Framework Agreement for up to a maximum of twenty four (24) months by giving a minimum of three (3) months written notice of such extension(s).

Lot 17 Gemcitabine Powder For Solution For Infusion Vials

Supply of Gemcitabine Powder For Solution For Infusion Vials to NHS Scotland. The Authority has awarded this Lot to a single supplier.

Renewal: The Authority is entitled at its sole discretion to extend the Framework Agreement for up to a maximum of twenty four (24) months by giving a minimum of three (3) months written notice of such extension(s).

Lot 18 Idarubicin Hydrochlioride Injection Powder For Reconstitution

Supply of Idarubicin Hydrochlioride Injection Powder For Reconstitution to NHS Scotland. The Authority has awarded this Lot to a single supplier.

Renewal: The Authority is entitled at its sole discretion to extend the Framework Agreement for up to a maximum of twenty four (24) months by giving a minimum of three (3) months written notice of such extension(s).

Lot 19 Ifosfamide Injection Powder For Reconstitution

Supply of Ifosfamide Injection Powder For Reconstitution to NHS Scotland. The Authority has awarded this Lot to a single supplier.

Renewal: The Authority is entitled at its sole discretion to extend the Framework Agreement for up to a maximum of twenty four (24) months by giving a minimum of three (3) months written notice of such extension(s).

Lot 20 Irinotecan Hydrochloride Injection

Supply of Irinotecan Hydrochloride Injection to NHS Scotland. The Authority has awarded this Lot to a single supplier.

Renewal: The Authority is entitled at its sole discretion to extend the Framework Agreement for up to a maximum of twenty four (24) months by giving a minimum of three (3) months written notice of such extension(s).

Lot 21 Lanreotide Injection Prefilled Syringes

Supply of Lanreotide Injection Prefilled Syringes to NHS Scotland. The Authority has awarded this Lot to a single supplier.

Renewal: The Authority is entitled at its sole discretion to extend the Framework Agreement for up to a maximum of twenty four (24) months by giving a minimum of three (3) months written notice of such extension(s).

Lot 22 Methotrexate Without Preservatives Injection

Supply of Methotrexate Without Preservatives Injection to NHS Scotland. The Authority has awarded this Lot to a single supplier.

Renewal: The Authority is entitled at its sole discretion to extend the Framework Agreement for up to a maximum of twenty four (24) months by giving a minimum of three (3) months written notice of such extension(s).

Lot 23 Methotrexate Oral Solution

Supply of Methotrexate Oral Solution to NHS Scotland. The Authority has awarded this Lot to a single supplier.

Renewal: The Authority is entitled at its sole discretion to extend the Framework Agreement for up to a maximum of twenty four (24) months by giving a minimum of three (3) months written notice of such extension(s).

Lot 24 Mitomycin Injection Powder For Reconstitution

Supply of Mitomycin Injection Powder For Reconstitution to NHS Scotland. The Authority has awarded this Lot to a single supplier.

Renewal: The Authority is entitled at its sole discretion to extend the Framework Agreement for up to a maximum of twenty four (24) months by giving a minimum of three (3) months written notice of such extension(s).

Lot 25 Octreotide Injection

Supply of Octreotide Injections to NHS Scotland. The Authority has awarded this Lot to a single supplier.

Renewal: The Authority is entitled at its sole discretion to extend the Framework Agreement for up to a maximum of twenty four (24) months by giving a minimum of three (3) months written notice of such extension(s).

Lot 26 Oxaliplatin Vial Solution

Supply of Oxaliplatin Vial Solution to NHS Scotland. The Authority has awarded this Lot to a single supplier.

Renewal: The Authority is entitled at its sole discretion to extend the Framework Agreement for up to a maximum of twenty four (24) months by giving a minimum of three (3) months written notice of such extension(s).

Lot 27 Paclitaxel Concentrate For Intravenous Infusion

Supply of Paclitaxel Concentrate For Intravenous Infusion to NHS Scotland. The Authority has awarded this Lot to a single supplier.

Renewal: The Authority is entitled at its sole discretion to extend the Framework Agreement for up to a maximum of twenty four (24) months by giving a minimum of three (3) months written notice of such extension(s).

Lot 28 Dasatinib

Supply of Dasatinib to NHS Scotland This Lot has not been awarded.

Renewal: The Authority is entitled at its sole discretion to extend the Framework Agreement for up to a maximum of twenty four (24) months by giving a minimum of three (3) months written notice of such extension(s).

Lot 29 Aprepitant

Supply of Aprepitant to NHS Scotland This Lot has not been awarded.

Renewal: The Authority is entitled at its sole discretion to extend the Framework Agreement for up to a maximum of twenty four (24) months by giving a minimum of three (3) months written notice of such extension(s).

Lot 30 Temozolomide Capsules

Supply of Temozolomide Capsules to NHS Scotland. The Authority has awarded this Lot to a single supplier.

Renewal: The Authority is entitled at its sole discretion to extend the Framework Agreement for up to a maximum of twenty four (24) months by giving a minimum of three (3) months written notice of such extension(s).

Lot 31 Topotecan Capsules

Supply of Topotecan Capsules to NHS Scotland. This Lot has not been awarded.

Renewal: The Authority is entitled at its sole discretion to extend the Framework Agreement for up to a maximum of twenty four (24) months by giving a minimum of three (3) months written notice of such extension(s).

Lot 32 Topotecan Concentrate For Solution For Infusion

Supply of Topotecan Concentrate For Solution For Infusion to NHS Scotland. This Lot has not been awarded.

Renewal: The Authority is entitled at its sole discretion to extend the Framework Agreement for up to a maximum of twenty four (24) months by giving a minimum of three (3) months written notice of such extension(s).

Lot 33 Vincristine Without Preservatives Injection

Supply of Vincristine Without Preservatives Injection to NHS Scotland. The Authority has awarded this Lot to a single supplier.

Renewal: The Authority is entitled at its sole discretion to extend the Framework Agreement for up to a maximum of twenty four (24) months by giving a minimum of three (3) months written notice of such extension(s).

Lot 36 Everolimus

Supply of Everolimus to NHS Scotland. This Lot has not been awarded.

Renewal: The Authority is entitled at its sole discretion to extend the Framework Agreement for up to a maximum of twenty four (24) months by giving a minimum of three (3) months written notice of such extension(s).

Lot 37 All Other Oncology Generic Products/Presentations

The supply of All Other Oncology Generic Products/Presentations to NHS Scotland. Each product line was treated as an individual lot and awarded to a single supplier for the full lot. The Authority has awarded this Lot to 20 suppliers.

Renewal: The Authority is entitled at its sole discretion to extend the Framework Agreement for up to a maximum of twenty four (24) months by giving a minimum of three (3) months written notice of such extension(s).

Lot 34 Vinorelbine Injection

Supply of Vinorelbine Injections to NHS Scotland. The Authority has awarded this Lot to a single supplier.

Renewal: The Authority is entitled at its sole discretion to extend the Framework Agreement for up to a maximum of twenty four (24) months by giving a minimum of three (3) months written notice of such extension(s).

Lot 35 Vinorelbine Capsules

Supply of Vinorelbine Capsules to NHS Scotland. This Lot has not been awarded.

Renewal: The Authority is entitled at its sole discretion to extend the Framework Agreement for up to a maximum of twenty four (24) months by giving a minimum of three (3) months written notice of such extension(s).

Publication & Lifecycle

Open Contracting ID
ocds-r6ebe6-0000554396
Publication Source
Public Contracts Scotland
Latest Notice
https://www.publiccontractsscotland.gov.uk/search/show/search_view.aspx?ID=JAN343204
Current Stage
Award
All Stages
Tender, Award

Procurement Classification

Notice Type
OJEU - F3 - Contract Award Notice
Procurement Type
Framework
Procurement Category
Goods
Procurement Method
Open
Procurement Method Details
Open procedure
Tender Suitability
Not specified
Awardee Scale
Large

Common Procurement Vocabulary (CPV)

CPV Divisions

33 - Medical equipments, pharmaceuticals and personal care products


CPV Codes

33600000 - Pharmaceutical products

Notice Value(s)

Tender Value
Not specified
Lots Value
£36,587,145 £10M-£100M
Awards Value
Not specified
Contracts Value
£18,742,949 £10M-£100M

Notice Dates

Publication Date
24 Jan 20197 years ago
Submission Deadline
29 Oct 2018Expired
Future Notice Date
Not specified
Award Date
24 Dec 20187 years ago
Contract Period
Not specified - Not specified
Recurrence
Not specified

Notice Status

Tender Status
Complete
Lots Status
Complete
Awards Status
Unsuccessful
Contracts Status
Active

Contracting Authority (Buyer)

Main Buyer
The Common Services Agency (more commonly known as NHS National Services Scotland) ("the Authority")
Contact Name
Available with D3 Tenders Premium →
Contact Email
Available with D3 Tenders Premium →
Contact Phone
Available with D3 Tenders Premium →

Buyer Location

Locality
EDINBURGH
Postcode
EH12 9EB
Postcode Area
Edinburgh
Country
Scotland

Major Region (ITL 1)
TLM Scotland
Basic Region (ITL 2)
TLM1 East Central Scotland
Small Region (ITL 3)
TLM13 City of Edinburgh
Delivery Location
TLM Scotland

Local Authority
City of Edinburgh
Electoral Ward
Drum Brae/Gyle
Westminster Constituency
Edinburgh South West

Supplier Information

Number of Suppliers
24
Supplier Names

Accord Healthcare Ltd

Aventis Pharma Ltd Trading As Sanofi

Baxter Healthcare Ltd

Consilient Health Ltd

Fresenius Kabi Limited

Fresenius Kabi Ltd

Glenmark Pharmaceuticals Europe Ltd

Intrapharm Laboratories Ltd

Ipsen Limited

Kent Pharmaceuticals Ltd

Kyowa Kirin

Martindale Pharma

Mercury Pharma Group

Morningside Pharmaceuticals Limited

Novartis Pharmaceuticals UK Ltd

Pfizer Ltd

Ranbaxy UK Ltd

Rosemont Pharmaceuticals Ltd

Sandoz Ltd

Selective Supplies Ltd

Teva UK Limited

Tillomed Laboratories Ltd

Zentiva Pharma UK Ltd

medac GmbH

Further Information

Notice Documents

  • https://www.publiccontractsscotland.gov.uk/search/show/search_view.aspx?ID=SEP332429
    Oncology Generics Medicines - This Framework Agreement is for the supply of a range of Oncology Generic Medicines to NHS Scotland, which will be awarded on a product line or lot by lot basis. As detailed below this framework is tendered using 37 Lots Lots 1-36 (except 11, 28 & 36) - All of the product lines included within each Lot will be grouped together as individual Lots and awarded to a single Framework Participant per Lot. Lots 11, 28 & 36 - Each product line will be treated as an individual Lot and be awarded on a line by line basis. Each Lot will be awarded as a ranked multi-supplier framework to an envisaged maximum of 6 Framework Participants per line. Lot 37 - Each product line within Lot 37 will be treated as an individual Lot and awarded to a single Framework Participant. Tenderers are invited to bid for as many Lots/lines as they wish. The individual descriptions and quantities are detailed within the tender documentation.
  • https://www.publiccontractsscotland.gov.uk/search/show/search_view.aspx?ID=JAN343204
    Oncology Generics Medicines - Supply of Oncology Generic Medicines to Health Boards across NHS Scotland

Open Contracting Data Standard (OCDS)

View full OCDS Record for this contracting process

JSON Markdown

The Open Contracting Data Standard (OCDS) is a framework designed to increase transparency and access to public procurement data in the public sector. It is widely used by governments and organisations worldwide to report on procurement processes and contracts.

Loading OCDS record...